Managing pollen asthma with a single inhaler: a case study
https://doi.org/10.21518/2079-701X-2015-11-36-41
Abstract
According to the definition proposed by the global leadership of GINA (Global Initiative for Asthma) in 2014, asthma is a heterogeneous disease, usually characterized by chronic airway inflammation. It is defined by the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity, together with variable expiratory airflow limitation. [1]
About the Author
N. M. Nenasheva
Russian Medical Academy of Postgraduate Education, Moscow
Russian Federation
Russian Federation
References
1. www.ginasthma. Com.
2. Akdis C, Agache I. Global Atlas of Asthma. Published by the EAACI, 2013, 180 p.
3. Calderon M, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol, 2015. 136: 38-48
4. Ненашева Н.М. Клинические фенотипы атопической бронхиальной астмы. Диагностика и лечение. Saarbrucken, Germany Palmarium Academic Publishing, 2012, 319 с.
5. Schappi GF, Taylor PE, Staff IA, Rolland JM, Suphioglu C. Immunologic significance of res-pirable atmospheric starch granules containing major birch allergen Bet v 1. Allergy, 1999. 54: 478-83.
6. Grote M, Vrtala S, Niederberger V, Valenta R, Reichelt R. Expulsion of allergen-containing materials from hydrated rye grass (Lolium per-enne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy. J Allergy Clin Immunol., 2000. 105: 1140-5.
7. Taylor PE, Flagan RC, Miguel AG, Valenta R, Glovsky MM. Birch pollen rupture and the release of aerosols of respirable allergens. Clin Exp Allergy, 2004. 34: 1591-6.
8. Wark PA, Simpson J, Hensley MJ, Gibson PG. Airway inflammation in thunderstorm asthma. Clin Exp Allergy, 2002. 32: 1750-6.
9. Bacsi A, Choudhury BK, Dharajiya N, Sur S, Boldogh I. Subpollen particles: Carriers of allergenic proteins and oxidases. The Journal of allergy and clinical immunology, 2006.118(4): 844-850.
10. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial. Am J Respir Crit Care Med, 2001. 163: 32-36.
11. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol. 1982. 70(4): 288-98.
12. Kelly M, O'Connor T, Leigh R, et al. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol, 2010. 125: 349-56.
13. Bateman ED, Harrison TW, Ouirce S, et al. Overall asthma control achieved with budeso-nide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res, 2011. 12: 38.
14. Архипов В.В., Григорьева Е.В., Гавришина Е.В. Контроль над бронхиальной астмой в России: результаты многоцентрового наблюдательного исследования НИКА. Пульмонология, 2011. 6: 87-93.
15. Nanshan Zhong, Jiangtao Lin, Parthiv Mehta, et al. Real-life Effectiveness of Budesonide/ Formoterol Maintenance and Reliever Therapy in Asthma Patients Across Asia. BMC Pulm Med., 2013. 13(22).
Review
For citations:
Nenasheva NM. Managing pollen asthma with a single inhaler: a case study. Meditsinskiy sovet = Medical Council. 2015;(11):36-41. (In Russ.) https://doi.org/10.21518/2079-701X-2015-11-36-41
Views:
652
Email this article 